| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.14B | 44.64B | 43.95B | 41.87B | 40.30B | 38.81B |
| Gross Profit | 9.73B | 9.71B | 9.46B | 9.06B | 8.89B | 8.80B |
| EBITDA | 4.99B | 4.80B | 5.22B | 4.76B | 5.01B | 5.16B |
| Net Income | 1.54B | 1.59B | 1.70B | 1.63B | 1.71B | 1.78B |
Balance Sheet | ||||||
| Total Assets | 68.49B | 69.17B | 70.46B | 68.70B | 65.14B | 69.23B |
| Cash, Cash Equivalents and Short-Term Investments | 8.08B | 6.93B | 10.29B | 8.94B | 10.85B | 14.73B |
| Total Debt | 19.36B | 20.23B | 21.54B | 20.06B | 18.72B | 23.86B |
| Total Liabilities | 33.28B | 32.44B | 34.89B | 34.53B | 32.31B | 37.58B |
| Stockholders Equity | 33.96B | 35.57B | 34.27B | 33.05B | 32.50B | 31.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 338.00M | 395.64M | 650.17M | 1.95B | 3.73B |
| Operating Cash Flow | 0.00 | 3.21B | 4.53B | 3.55B | 4.58B | 4.57B |
| Investing Cash Flow | 0.00 | -2.90B | -3.55B | -4.96B | -2.38B | -840.19M |
| Financing Cash Flow | 0.00 | -3.77B | -46.84M | -474.94M | -6.05B | 3.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥142.79B | 6.66 | 10.46% | 2.35% | 2.55% | 72.25% | |
76 Outperform | ¥540.72B | 9.78 | 6.90% | 2.71% | 4.41% | 176.65% | |
74 Outperform | ¥76.79B | 21.16 | ― | 6.64% | 2.45% | 1.87% | |
69 Neutral | ¥61.68B | 15.41 | ― | 3.31% | 2.25% | 30.32% | |
63 Neutral | ¥96.26B | 12.05 | 7.53% | 3.01% | 5.17% | 20.88% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥18.44B | 7.18 | ― | 4.39% | 1.59% | -5.58% |